MicroRNA-32 promotes calcification in vascular smooth muscle cells: Implications as a novel marker for coronary artery calcification

• Jianghua Liu ,

  Contributed equally to this work with: Jianghua Liu, Xinhua Xiao

  * E-mail: jianghua990@126.com (JL); zuxuyu0108@hotmail.com (XZ)

  Affiliations Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC), Department of Metabolism and Endocrinology, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Xinhua Xiao ,

  Contributed equally to this work with: Jianghua Liu, Xinhua Xiao

  Affiliation Department of Metabolism and Endocrinology, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Yingying Shen,

  Affiliation Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC)

  ⨯
• Ling Chen,

  Affiliation Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC)

  ⨯
• Canxin Xu,

  Affiliation Department of Pathology and Immunology, University of Washington School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Heng Zhao,

  Affiliation Department of Metabolism and Endocrinology, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Ying Wu,

  Affiliation Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC)

  ⨯
• Qinghai Zhang,

  Affiliation Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC)

  ⨯
• Jing Zhong,

  Affiliation Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC)

  ⨯
• Zhenwang Tang,

  Affiliation Department of Cardiovascular Medicine, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Changhui Liu,

  Affiliation Department of Cardiovascular Medicine, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Qiang Zhao,

  Affiliation Department of Metabolism and Endocrinology, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Yi Zheng,

  Affiliation Department of Metabolism and Endocrinology, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Renxian Cao,

  Affiliations Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC), Department of Metabolism and Endocrinology, the First Affiliated Hospital of University of South China, Hengyang, PRC

  ⨯
• Xuyu Zu

  * E-mail: jianghua990@126.com (JL); zuxuyu0108@hotmail.com (XZ)

  Affiliation Institute of Clinical Medicine, the First Affiliated Hospital of University of South China, Hengyang, People’s Republic of China (PRC)

  ⨯